Showing results (611-620 of 627) with videos related to

Sort By:
Pageof 63
Clinical Genitourinary Cancer|June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant ChemotherapyMin Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
Nature Cell Biology|November 9, 2021
Anatomical structures, cell types and biomarkers of the Human Reference AtlasKaty Börner, Sarah A Teichmann, Ellen M Quardokus, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Physical Review Letters|March 19, 2013
Interferometry with Bose-Einstein condensates in microgravityH Müntinga, H Ahlers, M Krutzik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II TrialSamuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyThomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial CarcinomaJonathan A Coleman, Wesley Yip, Nathan C Wong, et al.
Pageof 63